150 related articles for article (PubMed ID: 6254629)
1. Combination chemotherapy, radiotherapy, and BCG immunotherapy in extensive (metastatic) small cell carcinoma of the lung. A Southwest Oncology Group study.
McCracken JD; Heilbrun L; White J; Reed R; Samson M; Saiers JH; Stephens R; Stuckey WJ; Bickers J; Livingston R
Cancer; 1980 Dec; 46(11):2335-40. PubMed ID: 6254629
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy, radiotherapy, and BCG immunotherapy in limited small-cell carcinoma of the lung: a Southwest Oncology Group Study.
McCracken JD; Chen T; White J; Samson M; Stephens R; Coltman CA; Saiki J; Lane M; Bonnet J; McGavran M
Cancer; 1982 Jun; 49(11):2252-8. PubMed ID: 6280836
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy-radiotherapy with and without the methanol-extraction residue of Bacillus Calmette-Guerin (MER) in small cell carcinoma of the lung: a prospective randomized trial of the Piedmont Oncology Association.
Jackson DV; Paschal BR; Ferree C; Richards F; Muss HB; Cooper MR; White DR; Stuart JJ; Spurr CL; Wells B; Sartiano G; McFarland J; McCulloch J
Cancer; 1982 Jul; 50(1):48-52. PubMed ID: 6282434
[TBL] [Abstract][Full Text] [Related]
4. Chemoimmunotherapy of small cell bronchogenic carcinoma.
Holoye PY; Samuels ML; Smith T; Sinkovics JG
Cancer; 1978 Jul; 42(1):34-40. PubMed ID: 208755
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of lung cancer. II. Review of clinical trials in small cell carcinoma.
Mikulski SM; McGuire WP; Louie AC; Chirigos MA; Muggia FM
Cancer Treat Rev; 1979 Jun; 6(2):125-30. PubMed ID: 226262
[No Abstract] [Full Text] [Related]
6. BCG immunotherapy of lung cancer in a district oncology dispensary. I. Study of 860 patients with histologic diagnosis.
Hadźiev S; Mandulova P; Kavaklieva-Dimitrova J; Penev K; Spassova M; Madźarova S
Neoplasma; 1982; 29(1):93-110. PubMed ID: 6280082
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy with and without the methanol-extracted residue of bacillus Calmette-Guerin (MER) in extensive non-small-cell lung cancer: a prospective randomized study for the Piedmont Oncology Association.
Richards F; Howard V; Shore A; Muss HB; White DR; Jackson DV; Cooper MR; Bearden J; Stuart JJ; Sartiano G; Rhyne AL; Spurr CL
Cancer; 1981 Jun; 47(12):2827-32. PubMed ID: 6266642
[TBL] [Abstract][Full Text] [Related]
8. Combined modality therapy with radiotherapy, chemotherapy, and immunotherapy in limited small-cell carcinoma of the lung: a Phase III cancer and Leukemia Group B Study.
Maurer LH; Pajak T; Eaton W; Comis R; Chahinian P; Faulkner C; Silberfarb PM; Henderson E; Rege VB; Baldwin PE
J Clin Oncol; 1985 Jul; 3(7):969-76. PubMed ID: 2991478
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy versus chemoimmunotherapy for small-cell undifferentiated carcinoma of the lung.
Aisner J; Wiernik PH
Cancer; 1980 Dec; 46(12):2543-9. PubMed ID: 6256048
[TBL] [Abstract][Full Text] [Related]
10. Treatment of small cell lung cancer.
York RM
South Med J; 1981 Mar; 74(3):342-6. PubMed ID: 6261402
[TBL] [Abstract][Full Text] [Related]
11. Long-term results in combined-modality treatment of small cell carcinoma of the lung.
Einhorn LH; Bond WH; Hornback N; Joe BT
Semin Oncol; 1978 Sep; 5(3):309-13. PubMed ID: 211642
[TBL] [Abstract][Full Text] [Related]
12. Small-cell carcinoma of the lung: a five-year experience with combined modality therapy.
Hoffman PC; Golomb HM; Bitran JD; DeMeester TR; Cohen L; Griem ML; Cooksey JA; Mintz U; Gordon LI; Desser RK; Kinnealey AE; Sovik CA
Cancer; 1980 Dec; 46(12):2550-6. PubMed ID: 6256049
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant immunotherapy of lung cancer with BCG cell wall skeleton (BCG-CWS).
Yamamura Y; Sakatani M; Ogura T; Azuma I
Cancer; 1979 Apr; 43(4):1314-9. PubMed ID: 221088
[TBL] [Abstract][Full Text] [Related]
14. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
[TBL] [Abstract][Full Text] [Related]
15. Small cell cancer of the lung.
Carney DN; Minna JD
Clin Chest Med; 1982 May; 3(2):389-98. PubMed ID: 6284438
[No Abstract] [Full Text] [Related]
16. [Immunochemotherapy of lung neoplasms].
Ikegami H
Nihon Rinsho; 1980 Jul; 38(7):2691-700. PubMed ID: 6257950
[No Abstract] [Full Text] [Related]
17. Combination chemotherapy plus BCG in the treatment of disseminated malignant melanoma: a Southwest Oncology Group Study.
Costanzi JJ; Al-Sarraf M; Groppe C; Bottomley R; Fabian C; Neidhart J; Dixon D
Med Pediatr Oncol; 1982; 10(3):251-8. PubMed ID: 7045615
[TBL] [Abstract][Full Text] [Related]
18. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
Robinson E; Haim N; Segal R; Veseley Z; Mekori T
Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
[TBL] [Abstract][Full Text] [Related]
19. Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG.
Hortobagyi GN; Gutterman JU; Blumenschein GR; Tashima CK; Burgess MA; Einhorn L; Buzdar AU; Richman SP; Hersh EM
Cancer; 1979 Apr; 43(4):1225-33. PubMed ID: 445325
[TBL] [Abstract][Full Text] [Related]
20. Survival of lung cancer patients treated with BCG and/or a soluble BCG fraction (F70) after surgery, radiotherapy and chemotherapy.
Hadźiev S; Kavaklieva-Dimitrova J; Mandulova P; Madźarova S; Spassova M
Neoplasma; 1980; 27(1):83-94. PubMed ID: 7374861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
